Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »

For full access to this article login to GEN Select now.

Mar 3, 2014

The Top 25 Best-Selling Drugs of 2013

Find out how many billions these blockbusters raked in.

The Top 25 Best-Selling Drugs of 2013

These therapeutics didn’t bring in less than $3 billion last year. [© grandeduc - Fotolia.com]

  • #14. Neulasta (pegfilgrastim)

    Sponsor(s): Amgen2

    Indication(s): Neutropenia caused by cancer chemotherapy

    2013 sales: $4.392 billion

    2012 sales: $4.092 billion

    % Change: 7.3%

    Q4 2013 sales: $1.098 ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »